April 5, 2024
For Immediate Release: April 05, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the […]
April 5, 2024
Image One of the U.S. Food and Drug Administration’s jobs is to carefully evaluate the scientific data on a drug to be sure that it is […]
April 5, 2024
Summary Company Announcement Date: April 05, 2024 FDA Publish Date: April 05, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Product contains methanol Company […]
April 5, 2024
A group of researchers urged US regulators to revoke the approval of a test marketed for predicting risk for opioid addiction and said government health plans […]
April 5, 2024
Docket Number: FDA-2020-D-1794 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research FDA is announcing the availability of a guidance for industry entitled “Evaluation […]
April 5, 2024
The transplant team at Massachusetts General Hospital (MGH) reports that the recipient of the first-ever transplant of a genetically edited porcine kidney into a living human […]
April 5, 2024
Quick Links This page provides quick links to key guidances to support the submission of study data to FDA’s Center for Biologics Evaluation and Research (CBER), […]
April 5, 2024
As avian influenza continues to spread among wild bird populations in the European Union (EU), scientists have described a wide range of factors that could drive […]
April 5, 2024
[embedded content] Español 简体中文 한국어 Tagalog Việt While we remain vigilant to protect our families and communities from the spread of COVID-19, some […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148
Next page